open access

Vol 60, No 6 (2009)
Postgraduate education
Published online: 2009-12-30
Submitted: 2013-02-15
Get Citation

Peripheral precocious puberty

Robert Krysiak, Bogdan Marek, Bogusław Okopień
Endokrynologia Polska 2009;60(6):503-514.

open access

Vol 60, No 6 (2009)
Postgraduate education
Published online: 2009-12-30
Submitted: 2013-02-15

Abstract

The term precocious puberty is defined as the appearance of secondary sex characteristics before the age of 8 in girls and 9 in boys. There are two major forms of premature sexual maturation: gonadotrophin-dependent (central, or ’true’ precocious puberty) and gonadotrophin- independent precocious puberty. The latter, also called peripheral precocious puberty, is characterized by increased production of sex steroids, causing the typical physical changes of puberty, in the absence of reactivation of the hypothalamic-pituitary axis. It may result from several different disorders including testotoxicosis, McCune-Albright syndrome, congenital adrenal hyperplasia, adrenal and gonadal tumours. The accumulation of knowledge regarding the pathogenesis of symptoms and the development of safe, effective treatment modalities have led to earlier intervention in patients with peripheral precocious puberty to prevent the decline in their psychosocial wellbeing, adult height and quality of life. We review the ethiopathogenesis, clinical picture, diagnosis and treatment of various disorders causing peripheral precocious puberty and provide the reader with current recommendations concerning approach to the patient with this health problem.

Abstract

The term precocious puberty is defined as the appearance of secondary sex characteristics before the age of 8 in girls and 9 in boys. There are two major forms of premature sexual maturation: gonadotrophin-dependent (central, or ’true’ precocious puberty) and gonadotrophin- independent precocious puberty. The latter, also called peripheral precocious puberty, is characterized by increased production of sex steroids, causing the typical physical changes of puberty, in the absence of reactivation of the hypothalamic-pituitary axis. It may result from several different disorders including testotoxicosis, McCune-Albright syndrome, congenital adrenal hyperplasia, adrenal and gonadal tumours. The accumulation of knowledge regarding the pathogenesis of symptoms and the development of safe, effective treatment modalities have led to earlier intervention in patients with peripheral precocious puberty to prevent the decline in their psychosocial wellbeing, adult height and quality of life. We review the ethiopathogenesis, clinical picture, diagnosis and treatment of various disorders causing peripheral precocious puberty and provide the reader with current recommendations concerning approach to the patient with this health problem.
Get Citation

Keywords

testotoxicosis; McCune-Albright syndrome; congenital adrenal hyperplasia; adrenal and gonadal tumours; etiopathogenesis; symptoms; diagnosis; treatment

About this article
Title

Peripheral precocious puberty

Journal

Endokrynologia Polska

Issue

Vol 60, No 6 (2009)

Pages

503-514

Published online

2009-12-30

Bibliographic record

Endokrynologia Polska 2009;60(6):503-514.

Keywords

testotoxicosis
McCune-Albright syndrome
congenital adrenal hyperplasia
adrenal and gonadal tumours
etiopathogenesis
symptoms
diagnosis
treatment

Authors

Robert Krysiak
Bogdan Marek
Bogusław Okopień

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl